课题基金 / 基金详情

CENTER FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES: SARS-CoV-2 RESEARCH

CENTER FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES: SARS-CoV-2 RESEARCH
传染病结构生物学研究中心:SARS-CoV-2 研究
批准号:
10788156
负责人:
KARLA SATCHELL
金额:
$80.9万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2023-08-31

项目摘要

项目成果

KARLA SATCHELL的其他基金

相似基金

相关文献

中文摘要
翻译
应用最先进的高通量结构生物学技术对靶蛋白的三维原子结构进行实验表征,以推进通用流感疫苗的开发。该计划还支持利用3D结构信息和实验方法更好地表征蛋白质靶标的分子功能作用的研究项目。该中心的主要重点是病原体蛋白,预计这些蛋白将在生物医学研究中发挥重要的生物学作用和潜在影响。
英文摘要
To apply state-of-the-art, high-throughput structural biology technologies to experimentally characterize the three-dimensional atomic structure of targeted proteins to advance the development of a universal influenza vaccine. This program also supports research projects that utilize the 3D structure information and experimental approaches to better characterize the molecular functional role of protein targets. The primary focus of the Center is pathogen proteins that are expected to have an important biological role and a potential impact on biomedical research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CENTERSFOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES
TO PROVIDE SCIENTIFIC SUPPORT TO THE CENTERS FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES.
Center for Research on Structural Biology of Infectious Diseases: Universal Influenza Vaccine Research
CENTER FOR RESEARCH ON STRUCTURAL BIOLOGY OF INFECTIOUS DISEASES
海外基金